Literature DB >> 20950397

The Renpenning syndrome spectrum: new clinical insights supported by 13 new PQBP1-mutated males.

D Germanaud1, M Rossi, G Bussy, D Gérard, L Hertz-Pannier, P Blanchet, H Dollfus, F Giuliano, V Bennouna-Greene, P Sarda, S Sigaudy, A Curie, M C Vincent, R Touraine, V des Portes.   

Abstract

Since the first reports of polyglutamine-binding protein 1 (PQBP1) mutations in Renpenning syndrome and related disorders, the spectrum of PQBP1-linked clinical manifestations has been outlined from rare published case reports. The phenotypic description is often obtained from medical archives, and therefore, heterogeneous. Moreover, some aspects such as brain imaging or cognitive and behavioral functioning are rarely described. In this study, 13 PQBP1-mutated French patients were subjected to a standardized clinical, cognitive and behavioral assessment. Physical measurements of their relatives were also collected. We report on a recognizable clinical and radiological phenotype. All patients presented with microcephaly, leanness and mild short stature, relative to familial measurements. Three new clinical features are described: upper back progressive muscular atrophy, metacarpophalangeal ankylosis of the thumb and velar dysfunction. The specific facial dysmorphic features included at least four of the following signs: long triangular face, large ridged nose, half-depilated eyebrows, dysplastic or protruding ears and rough slightly sparse hair. An over-aged appearance was noticed in elderly patients. Cortical gyrification was normal based on available magnetic brain imaging of six patients. PQBP1-linked microcephaly (or Renpenning syndrome) is an X-linked mental retardation syndrome, which has clinically recognizable features.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20950397     DOI: 10.1111/j.1399-0004.2010.01551.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  18 in total

Review 1.  Friend or Foe: Innate Sensing of HIV in the Female Reproductive Tract.

Authors:  Nadia R Roan; Martin R Jakobsen
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

2.  The XLID protein PQBP1 and the GTPase Dynamin 2 define a signaling link that orchestrates ciliary morphogenesis in postmitotic neurons.

Authors:  Yoshiho Ikeuchi; Luis de la Torre-Ubieta; Takahiko Matsuda; Hanno Steen; Hitoshi Okazawa; Azad Bonni
Journal:  Cell Rep       Date:  2013-08-29       Impact factor: 9.423

3.  PQBP1 Is a Proximal Sensor of the cGAS-Dependent Innate Response to HIV-1.

Authors:  Janna Seifried; Stephen Soonthornvacharin; Sunnie M Yoh; Monika Schneider; Rana E Akleh; Kevin C Olivieri; Paul D De Jesus; Chunhai Ruan; Elisa de Castro; Pedro A Ruiz; David Germanaud; Vincent des Portes; Adolfo García-Sastre; Renate König; Sumit K Chanda
Journal:  Cell       Date:  2015-06-04       Impact factor: 41.582

4.  Transcriptome-directed analysis for Mendelian disease diagnosis overcomes limitations of conventional genomic testing.

Authors:  David R Murdock; Hongzheng Dai; Lindsay C Burrage; Jill A Rosenfeld; Shamika Ketkar; Michaela F Müller; Vicente A Yépez; Julien Gagneur; Pengfei Liu; Shan Chen; Mahim Jain; Gladys Zapata; Carlos A Bacino; Hsiao-Tuan Chao; Paolo Moretti; William J Craigen; Neil A Hanchard; Brendan Lee
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

5.  Renpenning Syndrome in a Turkish Patient: de novo Variant c.607C>T in PACS1 and Hypogammaglobulinemia Phenotype.

Authors:  Fatma Kurt Colak; Nilnur Eyerci; Caner Aytekin; Ayse S Eksioglu
Journal:  Mol Syndromol       Date:  2020-04-17

6.  Solution model of the intrinsically disordered polyglutamine tract-binding protein-1.

Authors:  Martin Rees; Christian Gorba; Cesira de Chiara; Tam T T Bui; Mitla Garcia-Maya; Alex F Drake; Hitoshi Okazawa; Annalisa Pastore; Dmitri Svergun; Yu Wai Chen
Journal:  Biophys J       Date:  2012-04-03       Impact factor: 4.033

7.  CCDC22: a novel candidate gene for syndromic X-linked intellectual disability.

Authors:  I Voineagu; L Huang; K Winden; M Lazaro; E Haan; J Nelson; J McGaughran; L S Nguyen; K Friend; A Hackett; M Field; J Gecz; D Geschwind
Journal:  Mol Psychiatry       Date:  2011-08-09       Impact factor: 15.992

8.  The splicing factor PQBP1 regulates mesodermal and neural development through FGF signaling.

Authors:  Yasuno Iwasaki; Gerald H Thomsen
Journal:  Development       Date:  2014-09-10       Impact factor: 6.868

9.  The Hippo signaling component LATS2 enhances innate immunity to inhibit HIV-1 infection through PQBP1-cGAS pathway.

Authors:  Tian-Sheng He; Longlong Dang; Jiahui Zhang; Junqi Zhang; Guiping Wang; Enlin Wang; Huan Xia; Weihong Zhou; Shian Wu; Xinqi Liu
Journal:  Cell Death Differ       Date:  2021-08-12       Impact factor: 15.828

10.  Heterozygous loss of WBP11 function causes multiple congenital defects in humans and mice.

Authors:  Ella M M A Martin; Annabelle Enriquez; Duncan B Sparrow; David T Humphreys; Aideen M McInerney-Leo; Paul J Leo; Emma L Duncan; Kavitha R Iyer; Joelene A Greasby; Eddie Ip; Eleni Giannoulatou; Delicia Sheng; Elizabeth Wohler; Clémantine Dimartino; Jeanne Amiel; Yline Capri; Daphné Lehalle; Adi Mory; Yael Wilnai; Yael Lebenthal; Ali G Gharavi; Grażyna G Krzemień; Monika Miklaszewska; Robert D Steiner; Cathy Raggio; Robert Blank; Hagit Baris Feldman; Hila Milo Rasouly; Nara L M Sobreira; Rebekah Jobling; Christopher T Gordon; Philip F Giampietro; Sally L Dunwoodie; Gavin Chapman
Journal:  Hum Mol Genet       Date:  2020-12-04       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.